Alzheimer’s Drugs Market Report by Drug Class (Donepezil, Galantamine, Rivastigmine, Memantine, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores, and Others), and Region 2025-2033

Alzheimer’s Drugs Market Report by Drug Class (Donepezil, Galantamine, Rivastigmine, Memantine, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2695

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Alzheimer’s Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Donepezil
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Galantamine
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Rivastigmine
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Memantine
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Distribution Channel
    7.1    Hospital Pharmacy
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Retail Pharmacy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Online Stores
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abbvie Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    AstraZeneca PLC
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Biogen Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Daiichi Sankyo Company Limited
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Eisai Co. Ltd.
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Eli Lilly and Company
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    H. Lundbeck A/S
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    F. Hoffmann-La Roche AG
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 SWOT Analysis
        13.3.9    Merck & Co. Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Novartis AG
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis
        13.3.11    Ono Pharmaceutical Co. Ltd.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 Financials
           13.3.11.4 SWOT Analysis
        13.3.12    Pfizer Inc.
           13.3.12.1 Company Overview
           13.3.12.2 Product Portfolio
           13.3.12.3 Financials
           13.3.12.4 SWOT Analysis
        13.3.13    Teva Pharmaceutical Industries Limited
           13.3.13.1 Company Overview
           13.3.13.2 Product Portfolio
           13.3.13.3 Financials
           13.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Alzheimer’s Drugs Market: Major Drivers and Challenges
Figure 2: Global: Alzheimer’s Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Alzheimer’s Drugs Market: Breakup by Drug Class (in %), 2024
Figure 4: Global: Alzheimer’s Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 5: Global: Alzheimer’s Drugs Market: Breakup by Region (in %), 2024
Figure 6: Global: Alzheimer’s Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: Global: Alzheimer’s Drugs (Donepezil) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Alzheimer’s Drugs (Donepezil) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Alzheimer’s Drugs (Galantamine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Alzheimer’s Drugs (Galantamine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Alzheimer’s Drugs (Rivastigmine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Alzheimer’s Drugs (Rivastigmine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Alzheimer’s Drugs (Memantine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Alzheimer’s Drugs (Memantine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Alzheimer’s Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Alzheimer’s Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Alzheimer’s Drugs (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Alzheimer’s Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Alzheimer’s Drugs (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Alzheimer’s Drugs (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Alzheimer’s Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Alzheimer’s Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: North America: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: North America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: United States: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: United States: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Canada: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Canada: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Asia Pacific: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Asia Pacific: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: China: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: China: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Japan: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Japan: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: India: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: India: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: South Korea: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: South Korea: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Australia: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Australia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Indonesia: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Indonesia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Others: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Europe: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Europe: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Germany: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Germany: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: France: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: France: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: United Kingdom: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: United Kingdom: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Italy: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Italy: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Spain: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Spain: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Russia: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Russia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Latin America: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Latin America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Brazil: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Brazil: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Mexico: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Mexico: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Others: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Middle East and Africa: Alzheimer’s Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Middle East and Africa: Alzheimer’s Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Global: Alzheimer’s Drugs Industry: SWOT Analysis
Figure 74: Global: Alzheimer’s Drugs Industry: Value Chain Analysis
Figure 75: Global: Alzheimer’s Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Alzheimer’s Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Alzheimer’s Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Alzheimer’s Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 4: Global: Alzheimer’s Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Alzheimer’s Drugs Market: Competitive Structure
Table 6: Global: Alzheimer’s Drugs Market: Key Players

Alzheimer’s Drugs Market Report by Drug Class (Donepezil, Galantamine, Rivastigmine, Memantine, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials